RuncheyResearch

Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive

Back to Forecasting

CXActive

Will the Colombia divestiture receive regulatory approval by year-end 2026?

Resolves January 15, 2027(193d)

IG: 0.48

Current Prediction

67%

Likely Yes

Model Agreement97%

Predictions9 runs

Last UpdatedApril 8, 2026

Why This Question Matters

Divesting Colombia at 10x EBITDA, removing FCPA jurisdiction. Expected year-end 2026 approval. Simplifies portfolio.

REGULATORY_EXPOSURE

Prediction Distribution

0%25%50%75%100%

opus

sonnet

haiku

Range: 63% – 72%Aggregate: 67%

Individual Predictions(9 runs)

opusRun 1

72%

See prediction context for full analysis.

See prediction-context.md

opusRun 2

70%

See prediction context for full analysis.

See prediction-context.md

opusRun 3

68%

See prediction context for full analysis.

See prediction-context.md

sonnetRun 1

65%

See prediction context for full analysis.

See prediction-context.md

sonnetRun 2

63%

See prediction context for full analysis.

See prediction-context.md

sonnetRun 3

67%

See prediction context for full analysis.

See prediction-context.md

haikuRun 1

68%

See prediction context for full analysis.

See prediction-context.md

haikuRun 2

65%

See prediction context for full analysis.

See prediction-context.md

haikuRun 3

67%

See prediction context for full analysis.

See prediction-context.md

Resolution Criteria

Resolves YES if regulatory approvals received by Dec 31, 2026. Resolves NO if pending.

Resolution Source

CX press release or filing

Source Trigger

Colombia exit at 10x EBITDA; removes FCPA jurisdiction; expected year-end 2026

regulatory-readerREGULATORY_EXPOSUREMEDIUM

View CX Analysis

Full multi-lens equity analysis